Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(50%)
Results Posted
100%(3 trials)

Phase Distribution

Ph early_phase_1
2
33%
Ph phase_2
3
50%
Ph not_applicable
1
17%

Phase Distribution

2

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
2(33.3%)
Phase 2Efficacy & side effects
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(3)

Detailed Status

Completed3
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (33.3%)
Phase 23 (50.0%)
N/A1 (16.7%)

Trials by Status

completed350%
recruiting350%

Recent Activity

3 active trials
Showing 5 of 6
recruitingearly_phase_1

The Role of NaV1.8 in Human Pain Models

NCT07511400
recruitingphase_2

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

NCT05705024
recruitingearly_phase_1

Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

NCT06882811
completednot_applicable

One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System

NCT03278223
completedphase_2

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

NCT02362646
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07511400Early Phase 1

The Role of NaV1.8 in Human Pain Models

Recruiting
NCT05705024Phase 2

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Recruiting
NCT06882811Early Phase 1

Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

Recruiting
NCT03278223Not Applicable

One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System

Completed
NCT02362646Phase 2

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

Completed
NCT01442129Phase 2

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6